GSK Operating Expenses

GSK plc American Depositary Shares (Each representing two Ordinary Shares) · Operating Expenses

GSK logo

GSK Operating Expenses

Latest reported£5.66B GBP
GSK Quarterly Operating Expenses · GBP (£0.00 → £5.66B)
High-resolution chart · PNG

GSK operating expenses history

Quarterly · GBP. Dates are reporting period ends; fiscal years can differ from calendar years.

GSK plc American Depositary Shares (Each representing two Ordinary Shares) Operating Expenses — Quarterly (GBP)
Period endingOperating Expenses (GBP)
5,662,000,000
3,461,000,000
4,455,000,000
3,696,000,000
3,798,000,000
3,363,000,000
4,862,000,000
5,426,000,000
4,116,000,000
3,903,000,000
5,061,000,000
3,926,000,000
3,105,000,000
2,926,000,000
3,270,000,000
4,215,000,000
3,672,000,000
2,180,000,000
4,952,000,000
3,231,000,000
2,855,000,000
3,245,000,000
4,507,000,000
3,903,000,000
2,325,000,000
3,877,000,000
3,749,000,000
3,993,000,000
3,688,000,000
3,500,000,000
3,739,000,000
3,546,000,000
4,221,000,000
3,591,000,000
4,569,000,000
3,314,000,000
4,721,000,000
3,153,000,000
4,483,000,000
3,586,000,000
4,559,000,000
3,373,000,000
3,999,000,000
2,898,000,000
3,548,000,000
-5,697,000,000
3,466,000,000
3,114,000,000
2,702,000,000
2,804,000,000
1,939,000,000
2,830,000,000
3,208,000,000
2,915,000,000
2,851,000,000
2,782,000,000
2,749,000,000
2,808,000,000
3,204,000,000
2,906,000,000
3,198,000,000
2,678,000,000
5,440,000,000
2,949,000,000
5,317,000,000
3,311,000,000
3,528,000,000
2,905,000,000
2,860,000,000
3,270,000,000
3,375,000,000
2,635,000,000
2,422,000,000
2,364,000,000
2,529,818,000
4,191,545,750
2,533,000,000
2,192,000,000
2,810,176,620
2,397,000,000
2,692,370,500
2,502,153,660
9,482,190,000
2,504,000,000
2,376,986,000
2,162,000,000
2,844,412,800
2,322,563,520
2,402,000,000
2,327,000,000
-328,095,000
5,967,695,000
2,396,378,080
2,455,621,920
3,066,000,000
2,764,000,000
2,664,000,000
2,558,000,000
1,828,034,910
2,845,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.